Ampio Pharmaceuticals, Inc.
AMPEDelisted Apr 4, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001411906
Ampio Pharmaceuticals, Inc. was delisted on Apr 4, 2024; its insiders filed their last Form 4 on Jun 13, 2023; 28 institutions reported holding it in 13F filings for Q1 2024, worth $34.2K in total; no superinvestor held it.
Q2 2021 vs. Q1 2021
How the institutions holding Ampio Pharmaceuticals, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 110 | 128 | +18 |
| Shares | 30.4M | 45.2M | +14.8M (+48.6%) |
| Value | $51.5M | $75.4M | +$23.9M (+46.4%) |
New holders (38)
Institutions that held Ampio Pharmaceuticals, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
Sold out (20)
Institutions that held Ampio Pharmaceuticals, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Millennium Management LLC | 1,910,256 | $3.23M |
| HRT Financial LP | 496,971 | $839.0K |
| ExodusPoint Capital Management, LP | 483,588 | $817.0K |
| Bank of Montreal | 360,000 | $662.0K |
| California Public Employees Retirement System | 364,714 | $616.0K |
| LMR Partners LLP | 113,897 | $192.0K |
| Diametric Capital, LP | 44,953 | $76.0K |
| Jefferies Group LLC | 37,800 | $63.9K |
| Schonfeld Strategic Advisors LLC | 34,638 | $58.0K |
| Qube Research & Technologies Ltd | 33,464 | $57.0K |
| Prelude Capital Management, LLC | 29,598 | $50.0K |
| Credit Suisse AG | 17,836 | $30.0K |
| Sciencast Management LP | 16,400 | $30.0K |
| Maven Securities LTD | 17,170 | $29.0K |
| First Republic Investment Management, Inc. | 15,000 | $25.0K |
| Capstone Investment Advisors, LLC | 14,719 | $25.0K |
| Cooper/Haims Advisors, LLC | 10,000 | $17.0K |
| Steward Partners Investment Advisory, LLC | 7,500 | $12.7K |
| Sowell Financial Services LLC | 6,000 | $10.0K |
| GPS Wealth Strategies Group, LLC | 1,000 | $1.00K |